What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Committed to rules
- Advanced to third reading
- 2nd report cal.
- 1st report cal.1084
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Includes within the schedules of controlled substances, any substances designated as controlled substances pursuant to the federal Analog Act
In Assembly Committee · Health · Sponsor Hakeem Jeffries
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:S7102
Title of bill
An act to amend the public health law, in relation to including substances designated pursuant to the federal Analog Act within the definition of controlled substances
Purpose or general idea of bill
This bill will give state drug and law enforcement agencies and individ- uals the another tool to combat the quickly moving world of designer drugs. The Federal Analog Act (21 use § 813) allows scheduling and enforcement against drugs which are substantially structurally similar to those in schedule I or II. This bill will incorporate substances scheduled under this act into New York State Public Health Law.
Summary of specific provisions
Section 1 amends Public Health Law Section 3306 to incorporate the Federal Analog Act into New York State's Drug Scheduling provisions.
Justification
Currently under New York State Law, only a narrow selection of scheduled substances have analog protection. That is, manufacturers often only need to chemically "tweak" a drug to avoid scheduling. This creates a game of cat and mouse, with legislation and enforcement far slower to act than the manufacturers of designer drugs.
On the federal level, the Drug Enforcement Agency is able to act on new, individual substances on a case-by-case basis through the use of the Federal Analog Act which schedules burgeoning substances "substantially similar to the chemical structure of a controlled substance in schedule I or II." This legislation incorporates this act into Public Health Law 3306 to give state enforcement another tool.
Prior legislative history
New Bill.
Fiscal implications
None to the State.
Effective date
This act shall take effect on the thirtieth day after it shall have become law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.